The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) - why and what?

被引:137
作者
Vestbo, Jorgen [1 ,2 ,3 ]
Hurd, Suzanne S. [4 ]
Rodriguez-Roisin, Roberto [5 ,6 ,7 ]
机构
[1] Odense Univ Hosp, Dept Resp Med J, DK-5000 Odense, Denmark
[2] Univ So Denmark, Inst Clin, Odense, Denmark
[3] Univ Manchester, Univ Hosp S Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Resp Res Grp, Manchester, Lancs, England
[4] Global Initiat Chron Obstruct Lung Dis, Vancouver, WA USA
[5] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Thorax Inst, Serv Pneumol, Barcelona, Spain
[6] Ciber Enfermedades Resp CIBERES, Barcelona, Spain
[7] Univ Barcelona, Hosp Clin, Barcelona, Spain
关键词
comorbidities; COPD; diagnosis; exacerbations; spirometry; OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; MORTALITY; EXACERBATIONS; FAILURE; RISK;
D O I
10.1111/crj.12002
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published a strategy for diagnosis and for management of chronic obstructive pulmonary disease (COPD) since 2001 and this has formed the basis for numerous national and regional guidelines. Objectives We describe the background for the 2011 revision of the GOLD document. Methods The GOLD document is updated annually and revised every 5 years based on published research as well as an evaluation by an expert panel of how to best formulate and disseminate knowledge on COPD. Results The GOLD 2011 revision states that spirometry is required for making a clinical diagnosis of COPD. At the same time, the document has less emphasis on spirometric evaluation of disease severity and launches a combined assessment taking symptoms, spirometry and history of exacerbations into account. This is matched with initial treatment for COPD where smoking cessation, pulmonary rehabilitation and physical activity in general are given high priority followed by pharmacologic treatment guided by the novel assessment scheme. Comorbidities are often present in COPD and the GOLD 2011 revision gives some guidance in how to manage these as well as how to manage COPD in the presence of comorbidities. Conclusion A more clinically oriented GOLD document will hopefully improve assessment and management of COPD.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 27 条
[11]   Lower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: An evidence-based review [J].
Hoesein, Firdaus A. A. Mohamed ;
Zanen, Pieter ;
Lammers, Jan-Willem J. .
RESPIRATORY MEDICINE, 2011, 105 (06) :907-915
[12]   Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease. [J].
Hurst, John R. ;
Vestbo, Jorgen ;
Anzueto, Antonio ;
Locantore, Nicholas ;
Muellerova, Hana ;
Tal-Singer, Ruth ;
Miller, Bruce ;
Lomas, David A. ;
Agusti, Alvar ;
MacNee, William ;
Calverley, Peter ;
Rennard, Stephen ;
Wouters, Emiel F. M. ;
Wedzicha, Jadwiga A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (12) :1128-1138
[13]   Frequent Chronic Obstructive Pulmonary Disease Exacerbators: How Much Real, How Much Fictitious? [J].
Jose Soler-Cataluna, Juan ;
Rodriguez-Roisin, Roberto .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (04) :276-284
[14]  
Lange Peter, 2007, Prim Care Respir J, V16, P174, DOI 10.3132/pcrj.2007.00030
[15]   Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis [J].
Lightowler, JV ;
Wedzicha, JA ;
Elliott, MW ;
Ram, FSF .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7382) :185-187
[16]   Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease - a population-based database study [J].
Madsen, Hanne ;
Brixen, Kim ;
Hallas, Jesper .
CLINICAL RESPIRATORY JOURNAL, 2010, 4 (01) :22-29
[17]   Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD [J].
Mannino, D. M. ;
Thorn, D. ;
Swensen, A. ;
Holguin, F. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (04) :962-969
[18]   Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study [J].
Mannino, DM ;
Doherty, DE ;
Buist, AS .
RESPIRATORY MEDICINE, 2006, 100 (01) :115-122
[19]  
Puhan MA, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005305.pub3, 10.1002/14651858.CD005305.pub4]
[20]   Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary [J].
Rabe, Klaus F. ;
Hurd, Suzanne ;
Anzueto, Antonio ;
Barnes, Peter J. ;
Buist, Sonia A. ;
Calverley, Peter ;
Fukuchi, Yoshinosuke ;
Jenkins, Christine ;
Rodriguez-Roisin, Roberto ;
van Weel, Chris ;
Zielinski, Jan .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (06) :532-555